Arrowhead Pharmaceuticals Inc banner

Wall St Price Targets

0HI3 Price Forecast
Based on 16 analysts

+84% Upside
from $58.12 today

Arrowhead Pharmaceuticals Inc (0HI3)’s 12-month stock price forecast through November 2027 has a consensus target of $107.18, implying 84% upside. The forecast is based on price targets from 16 Wall Street analysts.

0HI3 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 0HI3 yet.

Arrowhead Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0HI3's stock price target?
Price Target
107.18 USD

According to Wall Street analysts, the average 1-year price target for 0HI3 is 107.18 USD with a low forecast of 73.74 USD and a high forecast of 130.53 USD.

What is the Revenue forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Revenue has been 100%. The projected CAGR for the next 8 years is 25%.

What is the Operating Income forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
50%

The compound annual growth rate for Operating Income over the next 8 years is 50%.

Back to Top